IMU 4.26% 4.5¢ imugene limited

Hi @supertrampSorry but I think that the HER-vaxx trial also...

  1. 1,251 Posts.
    lightbulb Created with Sketch. 19
    Hi @supertramp

    Sorry but I think that the HER-vaxx trial also included local disease just like the Herceptin one. From the HER-vaxx inclusion criteria:

    "Metastatic gastric or GEJ adenocarcinoma, or locally advanced disease not amenable to surgical resection"

    https://clinicaltrials.gov/ct2/show/NCT02795988

    So far there is no data to suggest that HER-vaxx works better than Herceptin. I agree that this is not surprising at this stage given HER-vaxx and Herceptin have the same target ie HER2. We are hoping that the polyclonal antibodies stimulated by HER-vaxx have a more durable effect compared to Herceptin. Time will tell.

    Also, I note that the latest Edison research update states:

    "The HER2 B-cell vaccines have shown signs of efficacy in clinical studies despite the levels ofpolyclonal anti-HER2 antibodies stimulated by the vaccine being at least an order of magnitudelower than the levels used in anticancer therapy with Herceptin, which also acts on HER2."

    https://static1.squarespace.com/static/5b63d41b3e2d09b1f56bf483/t/5b7b7fa50ebbe8b7258f3ac5/1534820272676/Edison+report+final+16aug18.pdf
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
-0.002(4.26%)
Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.